SG11201605917SA - 6-phenyl- or 6-(pyridin-3-yl)indazole derivatives and methods of use - Google Patents
6-phenyl- or 6-(pyridin-3-yl)indazole derivatives and methods of useInfo
- Publication number
- SG11201605917SA SG11201605917SA SG11201605917SA SG11201605917SA SG11201605917SA SG 11201605917S A SG11201605917S A SG 11201605917SA SG 11201605917S A SG11201605917S A SG 11201605917SA SG 11201605917S A SG11201605917S A SG 11201605917SA SG 11201605917S A SG11201605917S A SG 11201605917SA
- Authority
- SG
- Singapore
- Prior art keywords
- pyridin
- phenyl
- methods
- indazole derivatives
- indazole
- Prior art date
Links
- LBFQCQQOSUESGH-UHFFFAOYSA-N 6-pyridin-3-yl-1h-indazole Chemical class C=1C=C2C=NNC2=CC=1C1=CC=CN=C1 LBFQCQQOSUESGH-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461931137P | 2014-01-24 | 2014-01-24 | |
| PCT/US2015/011760 WO2015112445A1 (en) | 2014-01-24 | 2015-01-16 | 6-phenyl- or 6-(pyridin-3-yl)indazole derivatives and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201605917SA true SG11201605917SA (en) | 2016-08-30 |
Family
ID=52462430
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201605917SA SG11201605917SA (en) | 2014-01-24 | 2015-01-16 | 6-phenyl- or 6-(pyridin-3-yl)indazole derivatives and methods of use |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20160376240A1 (en) |
| EP (1) | EP3097091A1 (en) |
| JP (1) | JP2017503838A (en) |
| CA (1) | CA2937111A1 (en) |
| MX (1) | MX2016009581A (en) |
| SG (1) | SG11201605917SA (en) |
| WO (1) | WO2015112445A1 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016096709A1 (en) | 2014-12-16 | 2016-06-23 | Eudendron S.R.L. | Heterocyclic derivatives modulating activity of certain protein kinases |
| AU2018312349A1 (en) | 2017-08-01 | 2020-02-06 | Theravance Biopharma R&D Ip, Llc | Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors |
| CA3099384A1 (en) | 2018-05-16 | 2018-11-29 | George Swope MUNDAY | Apparatus and method for closing a surgical site |
| IL280984B2 (en) * | 2018-08-22 | 2025-02-01 | Cullgen Shanghai Inc | Tropomyosin receptor kinase (trk) degradation compounds and methods of use |
| US11969472B2 (en) | 2018-08-22 | 2024-04-30 | Cullgen (Shanghai), Inc. | Tropomyosin receptor kinase (TRK) degradation compounds and methods of use |
| EP3914348A1 (en) | 2019-01-23 | 2021-12-01 | Theravance Biopharma R&D IP, LLC | Imidazo[1,5-a]pyridine, 1,2,4-triazolo[4,3-a]pyridine and imidazo[1,5-a]pyrazine as jak inhibitors |
| EP4110772A4 (en) | 2020-02-26 | 2024-04-03 | Cullgen (Shanghai), Inc. | TROPOMYOSIN RECEPTOR KINASE (TRK) DEGRADATION COMPOUNDS AND METHODS OF USE |
| US11701104B2 (en) | 2021-06-08 | 2023-07-18 | George Swope MUNDAY | Apparatus for closing a surgical site |
| US20220387023A1 (en) | 2021-06-08 | 2022-12-08 | George Swope MUNDAY | Apparatus for closing a surgical site |
| US12471911B2 (en) | 2022-01-10 | 2025-11-18 | George Swope Munday | Apparatus for closing a surgical site |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002353186A1 (en) * | 2001-12-19 | 2003-06-30 | Smithkline Beecham P.L.C. | (1-h-indazol-3-yl) -amide derivatives as gsk-3 inhibitors |
| FR2836915B1 (en) * | 2002-03-11 | 2008-01-11 | Aventis Pharma Sa | AMINOINDAZOLE DERIVATIVES, PREPARATION METHOD AND INTERMEDIATES THEREOF AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME |
| WO2003097610A1 (en) * | 2002-05-17 | 2003-11-27 | Pharmacia Italia S.P.A. | Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| DE102004028862A1 (en) * | 2004-06-15 | 2005-12-29 | Merck Patent Gmbh | 3-aminoindazoles |
| JP5502858B2 (en) * | 2008-06-05 | 2014-05-28 | グラクソ グループ リミテッド | 4-Carboxamide indazole derivatives useful as inhibitors of PI3 kinase |
| TWI516487B (en) * | 2009-04-30 | 2016-01-11 | 葛蘭素集團有限公司 | Novel compounds, pharmaceutical compositions thereof and use as inhibitors of kinase activity |
| WO2013176970A1 (en) * | 2012-05-22 | 2013-11-28 | Merck Sharp & Dohme Corp. | TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF |
-
2015
- 2015-01-16 WO PCT/US2015/011760 patent/WO2015112445A1/en not_active Ceased
- 2015-01-16 JP JP2016548152A patent/JP2017503838A/en active Pending
- 2015-01-16 SG SG11201605917SA patent/SG11201605917SA/en unknown
- 2015-01-16 EP EP15703161.8A patent/EP3097091A1/en not_active Withdrawn
- 2015-01-16 MX MX2016009581A patent/MX2016009581A/en unknown
- 2015-01-16 US US15/112,870 patent/US20160376240A1/en not_active Abandoned
- 2015-01-16 CA CA2937111A patent/CA2937111A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MX2016009581A (en) | 2017-04-27 |
| CA2937111A1 (en) | 2015-07-30 |
| JP2017503838A (en) | 2017-02-02 |
| WO2015112445A1 (en) | 2015-07-30 |
| US20160376240A1 (en) | 2016-12-29 |
| EP3097091A1 (en) | 2016-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL288243A (en) | Heteroaryl substituted pyridines and methods of use | |
| IL250415B (en) | Anti-pdl- antibodies and methods of use thereof | |
| IL256032A (en) | Substituted pyridines and method of use | |
| SG11201605917SA (en) | 6-phenyl- or 6-(pyridin-3-yl)indazole derivatives and methods of use | |
| ZA201608116B (en) | Wireline system and methods of using same | |
| IL252560A0 (en) | Heterocyclic derivatives and use thereof | |
| IL248529A0 (en) | Pladienolide pyridine compounds and methods of use | |
| HUE050761T2 (en) | Compounds and methods of use | |
| LT3551209T (en) | Insulin-fc fusions and methods of use | |
| GB201417048D0 (en) | Occupancy-control device and methods of use | |
| GB2546006B (en) | Downhole apparatus and methods of use | |
| IL252199A0 (en) | Spray-drying apparatus and method of use | |
| EP3194377A4 (en) | Heterocycle substituted amino-pyridine compounds and methods of use thereof | |
| IL250484A0 (en) | Heterobicyclic cpmpounds and their use for the treatment of tuberculosis | |
| SG11201605915WA (en) | Furo-3-carboxamide derivatives and methods of use | |
| ZA201606450B (en) | Compounds and their methods of use | |
| IL258690A (en) | Pyridone derivatives and their use as kinase inhibitors | |
| GB201403697D0 (en) | Compounds and methods of use | |
| GB201522746D0 (en) | Downhole apparatus and methods of use | |
| GB201408738D0 (en) | Components and methods for formulation of components | |
| GB201416797D0 (en) | Contianer and method of use thereof | |
| GB201407831D0 (en) | User feedback system and method of use thereof | |
| GB201403291D0 (en) | Ordering system and method of use thereof |